The Valley Desk

NCT05564650 · Interventional trial

Navitoclax in Relapsed or Refractory High-Risk Myelodysplastic Syndrome

Overall registry status Completed

Phase 1

Conditions Myelodysplastic Syndrome, Recurrent Myelodysplastic Syndrome, Refractory Myelodysplastic Syndrome

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov